|
Apr 17
|
Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results
|
|
Mar 14
|
Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?
|
|
Mar 11
|
Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS Forum
|
|
Feb 27
|
Q4 2024 Vir Biotechnology Inc Earnings Call
|
|
Feb 25
|
Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day
|
|
Feb 18
|
SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag
|
|
Feb 14
|
Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y
|
|
Feb 14
|
Alnylam Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 14
|
Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Feb 14
|
Q4 2024 Alnylam Pharmaceuticals Inc Earnings Call
|
|
Feb 13
|
Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say
|
|
Feb 13
|
Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates
|
|
Feb 13
|
Alnylam: Q4 Earnings Snapshot
|
|
Feb 13
|
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress
|
|
Feb 12
|
Biogen's Q4 Earnings & Sales Beat, 2025 EPS Guidance Disappoints
|
|
Feb 11
|
ILMN vs. ALNY: Which Stock Is the Better Value Option?
|
|
Feb 10
|
Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?
|
|
Feb 10
|
Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
|
|
Feb 7
|
Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
|